220 related articles for article (PubMed ID: 11785958)
1. Expression and functional analyses of novel mutations of ATP-binding cassette transporter-1 in Japanese patients with high-density lipoprotein deficiency.
Nishida Y; Hirano K; Tsukamoto K; Nagano M; Ikegami C; Roomp K; Ishihara M; Sakane N; Zhang Z; Tsujii Ki K; Matsuyama A; Ohama T; Matsuura F; Ishigami M; Sakai N; Hiraoka H; Hattori H; Wellington C; Yoshida Y; Misugi S; Hayden MR; Egashira T; Yamashita S; Matsuzawa Y
Biochem Biophys Res Commun; 2002 Jan; 290(2):713-21. PubMed ID: 11785958
[TBL] [Abstract][Full Text] [Related]
2. Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene mutations.
Mott S; Yu L; Marcil M; Boucher B; Rondeau C; Genest J
Atherosclerosis; 2000 Oct; 152(2):457-68. PubMed ID: 10998475
[TBL] [Abstract][Full Text] [Related]
3. Truncation mutations in ABCA1 suppress normal upregulation of full-length ABCA1 by 9-cis-retinoic acid and 22-R-hydroxycholesterol.
Wellington CL; Yang YZ; Zhou S; Clee SM; Tan B; Hirano K; Zwarts K; Kwok A; Gelfer A; Marcil M; Newman S; Roomp K; Singaraja R; Collins J; Zhang LH; Groen AK; Hovingh K; Brownlie A; Tafuri S; Genest J; Kastelein JJ; Hayden MR
J Lipid Res; 2002 Nov; 43(11):1939-49. PubMed ID: 12401893
[TBL] [Abstract][Full Text] [Related]
4. Severe HDL deficiency due to novel defects in the ABCA1 transporter.
Pisciotta L; Bocchi L; Candini C; Sallo R; Zanotti I; Fasano T; Chakrapani A; Bates T; Bonardi R; Cantafora A; Ball S; Watts G; Bernini F; Calandra S; Bertolini S
J Intern Med; 2009 Mar; 265(3):359-72. PubMed ID: 19019193
[TBL] [Abstract][Full Text] [Related]
5. cAMP induces ABCA1 phosphorylation activity and promotes cholesterol efflux from fibroblasts.
Haidar B; Denis M; Krimbou L; Marcil M; Genest J
J Lipid Res; 2002 Dec; 43(12):2087-94. PubMed ID: 12454270
[TBL] [Abstract][Full Text] [Related]
6. Oxidized LDL upregulated ATP binding cassette transporter-1 in THP-1 macrophages.
Tang CK; Yi GH; Yang JH; Liu LS; Wang Z; Ruan CG; Yang YZ
Acta Pharmacol Sin; 2004 May; 25(5):581-6. PubMed ID: 15132822
[TBL] [Abstract][Full Text] [Related]
7. Tangier disease caused by compound heterozygosity for ABCA1 mutations R282X and Y1532C.
Cameron J; Ranheim T; Halvorsen B; Kulseth MA; Leren TP; Berge KE
Atherosclerosis; 2010 Mar; 209(1):163-6. PubMed ID: 19765707
[TBL] [Abstract][Full Text] [Related]
8. Two novel missense mutations in ABCA1 result in altered trafficking and cause severe autosomal recessive HDL deficiency.
Albrecht C; Baynes K; Sardini A; Schepelmann S; Eden ER; Davies SW; Higgins CF; Feher MD; Owen JS; Soutar AK
Biochim Biophys Acta; 2004 May; 1689(1):47-57. PubMed ID: 15158913
[TBL] [Abstract][Full Text] [Related]
9. Cellular physiology of cholesterol efflux in vascular endothelial cells.
O'Connell BJ; Denis M; Genest J
Circulation; 2004 Nov; 110(18):2881-8. PubMed ID: 15492319
[TBL] [Abstract][Full Text] [Related]
10. Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency.
Fasano T; Zanoni P; Rabacchi C; Pisciotta L; Favari E; Adorni MP; Deegan PB; Park A; Hlaing T; Feher MD; Jones B; Uzak AS; Kardas F; Dardis A; Sechi A; Bembi B; Minuz P; Bertolini S; Bernini F; Calandra S
Mol Genet Metab; 2012 Nov; 107(3):534-41. PubMed ID: 22959828
[TBL] [Abstract][Full Text] [Related]
11. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion.
Koldamova RP; Lefterov IM; Ikonomovic MD; Skoko J; Lefterov PI; Isanski BA; DeKosky ST; Lazo JS
J Biol Chem; 2003 Apr; 278(15):13244-56. PubMed ID: 12547833
[TBL] [Abstract][Full Text] [Related]
12. The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.
Neufeld EB; Stonik JA; Demosky SJ; Knapper CL; Combs CA; Cooney A; Comly M; Dwyer N; Blanchette-Mackie J; Remaley AT; Santamarina-Fojo S; Brewer HB
J Biol Chem; 2004 Apr; 279(15):15571-8. PubMed ID: 14747463
[TBL] [Abstract][Full Text] [Related]
13. Impaired ABCA1-dependent lipid efflux and hypoalphalipoproteinemia in human Niemann-Pick type C disease.
Choi HY; Karten B; Chan T; Vance JE; Greer WL; Heidenreich RA; Garver WS; Francis GA
J Biol Chem; 2003 Aug; 278(35):32569-77. PubMed ID: 12813037
[TBL] [Abstract][Full Text] [Related]
14. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.
Du XM; Kim MJ; Hou L; Le Goff W; Chapman MJ; Van Eck M; Curtiss LK; Burnett JR; Cartland SP; Quinn CM; Kockx M; Kontush A; Rye KA; Kritharides L; Jessup W
Circ Res; 2015 Mar; 116(7):1133-42. PubMed ID: 25589556
[TBL] [Abstract][Full Text] [Related]
15. A novel missense mutation of ABCA1 in transmembrane alpha-helix in a Japanese patient with Tangier disease.
Maekawa M; Kikuchi J; Kotani K; Nagao K; Odgerel T; Ueda K; Kawano M; Furukawa Y; Sakurabayashi I
Atherosclerosis; 2009 Sep; 206(1):216-22. PubMed ID: 19344898
[TBL] [Abstract][Full Text] [Related]
16. Clinical variant of Tangier disease in Japan: mutation of the ABCA1 gene in hypoalphalipoproteinemia with corneal lipidosis.
Ishii J; Nagano M; Kujiraoka T; Ishihara M; Egashira T; Takada D; Tsuji M; Hattori H; Emi M
J Hum Genet; 2002; 47(7):366-9. PubMed ID: 12111371
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-I activates cellular cAMP signaling through the ABCA1 transporter.
Haidar B; Denis M; Marcil M; Krimbou L; Genest J
J Biol Chem; 2004 Mar; 279(11):9963-9. PubMed ID: 14701824
[TBL] [Abstract][Full Text] [Related]
18. The role of the ABCA1 transporter and cholesterol efflux in familial hypoalphalipoproteinemia.
Hovingh GK; Van Wijland MJ; Brownlie A; Bisoendial RJ; Hayden MR; Kastelein JJ; Groen AK
J Lipid Res; 2003 Jun; 44(6):1251-5. PubMed ID: 12700344
[TBL] [Abstract][Full Text] [Related]
19. Native LDL upregulation of ATP-binding cassette transporter-1 in human vascular endothelial cells.
Liao H; Langmann T; Schmitz G; Zhu Y
Arterioscler Thromb Vasc Biol; 2002 Jan; 22(1):127-32. PubMed ID: 11788472
[TBL] [Abstract][Full Text] [Related]
20. An ABCA1 truncation shows no dominant negative effect in a familial hypoalphalipoproteinemia pedigree with three ABCA1 mutations.
Sorrenson B; Suetani RJ; Bickley VM; George PM; Williams MJ; Scott RS; McCormick SP
Biochem Biophys Res Commun; 2011 Jun; 409(3):400-5. PubMed ID: 21575609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
